PREVICOX Comprimé (à mâcher)

Pays: Canada

Langue: français

Source: Health Canada

Achète-le

Notice patient Notice patient (PIL)
07-06-2023

Ingrédients actifs:

Firocoxib

Disponible depuis:

BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.

Dosage:

57MG

forme pharmaceutique:

Comprimé (à mâcher)

Composition:

Firocoxib 57MG

Mode d'administration:

Orale

Unités en paquet:

15G/50G

Type d'ordonnance:

Prescription

Groupe thérapeutique:

Chiens

Descriptif du produit:

Numéro de groupe d'ingrédients actifs (GIA) :0152300001

Statut de autorisation:

APPROUVÉ

Date de l'autorisation:

2020-06-10

Notice patient

                                BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
PREVICOX
® (FIROCOXIB) 57 MG & 227 MG TABLETS /PROPOSED LABELING COMPONENTS
BI AH Canada Inc. Version dated 07Jun2023
PACKAGE INSERT - EN
PR
PREVICOX
®
(FIROCOXIB)
Chewable Tablets for Dogs
VETERINARY USE ONLY
DIN 02300168 (57mg)/DIN 02300176 (227mg)
_DESCRIPTION_: Previcox
®
(firocoxib) is a selective COX-2 enzyme inhibiting-class, non-
narcotic, non-steroidal anti-inflammatory drug. Firocoxib is a white
crystalline compound
described chemically as 3-(cyclopropylmethoxy)-4-(4-(methylsulfonyl)
phenyl)-5,5-
dimethylfuranone. The empirical formula is C
17
H
20
0
5
S, and the molecular weight is 336.4
g/mol. The structural formula is:
_INDICATIONS_: Previcox
®
(firocoxib) chewable tablets are indicated for the control of pain and
inflammation associated with osteoarthritis and for the control of
postoperative pain and
inflammation associated with soft-tissue and orthopedic surgery in
dogs.
_DOSAGE AND ADMINISTRATION:_ For OSTEOARTHRITIS, the recommended
dosage of Previcox
®
(firocoxib) for oral administration in dogs is 5 mg/kg body weight
once daily. For post-
operative pain and inflammation following SOFT-TISSUE and ORTHOPEDIC
SURGERY, the
recommended dosage is 5 mg/kg body weight once daily, starting
approximately 2 hours
prior to surgery and for 2 additional days. Previcox
®
tablets are scored and dosage should
be calculated in half tablet increments. DUE TO TABLET SIZE AND
SCORING, DOGS WEIGHING
LESS THAN 5.7 KG (12.5 LBS) CANNOT BE ACCURATELY DOSED. Previcox
®
tablets may be
administered with or without food.
OWNERS SHOULD BE INFORMED OF THE POTENTIAL ADVERSE REACTIONS AND
CLINICAL SIGNS
ASSOCIATED WITH NSAID INTOLERANCE. ALWAYS PROVIDE CLIENT INFORMATION
SHEET WITH
PRESCRIPTION. DOGS UNDERGOING PROLONGED TREATMENT WITH PREVICOX
® SHOULD BE
MONITORED PERIODICALLY.
_CONTRA-INDICATIONS:_ Do not administer Previcox
®
or any NSAID if gastro-intestinal ulceration
or bleeding is suspected. Do not administer concurrently with
corticosteroids or other non-
steroi
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient anglais 07-06-2023

Rechercher des alertes liées à ce produit